Product/Operations Update
Rainbow Childrens Medicare Ltd: Guntur Hospital Commenced
Rainbow Childrens Medicare Ltd has commenced operations of a 50-bed women's and children's hospital at Guntur, Andhra Pradesh, disclosed on Sep 16, 2026.

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
2
Neutral
8
Bullish
4
Bearish
24
Neutral
8
Bullish
14
Bearish
22
Neutral
0
Bullish
10
Healthcare Services
Hospital
14,770 Cr
Low Risk
50.9
65.3
2.8
8.9
1,609.00
1,008.75
Sales CAGR
Profit CAGR
ROE
ROCE
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone

Rainbow Childrens Medicare Ltd (RAINBOW) is currently trading at 1,447.65 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Rainbow Children's Medicare Limited is a leading pediatric and obstetrics healthcare provider in India, operating 23 hospitals across 9 cities. Its network includes pediatric, neonatal, and perinatal care services, with a doctor engagement model that ensures 24/7 care by full-time specialists. The company has seen a steady improvement in operational metrics, with a 12% revenue growth in Q3 FY26. Its focus on capacity expansion has resulted in new facilities in regions like Rajahmundry and Bengaluru, bolstering its presence in Southern India. Significant emphasis is on building comprehensive pediatric care with synergies between pediatric and perinatal services. The hub-and-spoke operating model facilitates extensive regional coverage, offering tertiary and quaternary care in central hubs. Rainbow's strategic plans involve further digital transformation initiatives aimed at enhancing patient engagement and experience. This is aligned with their goal to provide a seamless healthcare journey, integrating digital tools for better accessibility and efficiency. The recent onboarding of Mr. Abrarali Dalal as the Group CEO is expected to drive the next phase of operational excellence and expansion, leveraging his extensive experience in healthcare to optimize growth and service delivery.
Over the past 52 weeks, Rainbow Childrens Medicare Ltd has traded between a low of ₹1,008.75 and a high of ₹1,609.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Rainbow Childrens Medicare Ltd has a market capitalization of approximately 14,770.33. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Rainbow Childrens Medicare Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 50.88 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 14,770.33 Cr, Rainbow Childrens Medicare Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Rainbow Childrens Medicare Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Rainbow Childrens Medicare Ltd is 50.88. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
The source reports a claimed consolidated net profit of about INR 606 million (₹60.57 crore), up from about INR 534 million year-on-year, with a note that the latest figure is not independently verified.
Net profit (PAT) for Q1 FY27 was reported at ₹605.7 million, up from ₹535.0 million in Q1 FY26.
Management guided for revenue growth in the late-teens to 20% in FY26, with Q1 expected to be seasonally soft and the next three quarters healthier.
